How Psychedelics Can Offer Transcendence At End Of Life

2017 ⸱ 

Anthony P. Bossis, PhD


Existential despair, anxiety and depression are all too common at the end of life. Psychologist Anthony Bossis conducts FDA-approved research to understand how, through a single psilocybin-induced therapeutic experience, these symptoms might be alleviated or even transformed – into acceptance, enhanced wellbeing and personal meaning.

About the speaker(s)

Anthony P. Bossis, PhD, is a clinical psychologist and clinical assistant professor of psychiatry at NYU School of Medicine conducting FDA approved psychedelic research investigating the therapeutic efficacy of psilocybin on existential and psycho-spiritual distress at the end of life. He is a co-founder of Palliative Care Service at Bellevue Hospital and on the advisory committee and faculty for the Art of Dying Institute in New York City where he maintains a private psychotherapy practice.

Show more

Help us change the way we die

Join the Movement

Get the latest news and fresh ideas from the frontlines of all things end of life.